(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
-4.85% $ 4.71
Live Chart Being Loaded With Signals
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States...
Stats | |
---|---|
Объем за сегодня | 59 942.00 |
Средний объем | 51 603.00 |
Рыночная капитализация | 84.99M |
EPS | $0 ( 2024-03-26 ) |
Дата следующего отчета о доходах | ( $-0.280 ) 2024-05-09 |
Last Dividend | $0.300 ( 2022-05-24 ) |
Next Dividend | $0 ( N/A ) |
P/E | -4.81 |
ATR14 | $0.0360 (0.76%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-17 | Karkus Ted William | Buy | 400 000 | Option (right to buy) |
2024-01-01 | Latkin Jed | Buy | 500 000 | Option (right to buy) |
2024-01-01 | Latkin Jed | Buy | 0 | |
2024-03-17 | Hirsch Warren | Buy | 70 000 | Option (right to buy) |
2024-03-17 | Gleckel Louis Md | Buy | 70 000 | Option (right to buy) |
INSIDER POWER |
---|
18.10 |
Last 98 transactions |
Buy: 8 777 863 | Sell: 8 858 292 |
Объем Корреляция
Prophase Labs Inc Корреляция
10 Самые положительные корреляции | |
---|---|
RMCF | 0.955 |
CLFD | 0.955 |
CRON | 0.939 |
CMRX | 0.938 |
EVLO | 0.937 |
BMRA | 0.93 |
PCSA | 0.929 |
ADP | 0.928 |
DRUG | 0.926 |
BFC | 0.922 |
10 Самые отрицательные корреляции | |
---|---|
GXII | -0.94 |
CFFE | -0.933 |
ARTEU | -0.933 |
BRIVU | -0.932 |
TRHC | -0.932 |
MSAC | -0.929 |
VHNA | -0.928 |
AMTBB | -0.927 |
EMLD | -0.927 |
ATEC | -0.926 |
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
Prophase Labs Inc Корреляция - Валюта/Сырье
Prophase Labs Inc Финансовые показатели
Annual | 2023 |
Выручка: | $44.38M |
Валовая прибыль: | $16.24M (36.59 %) |
EPS: | $-0.980 |
FY | 2023 |
Выручка: | $44.38M |
Валовая прибыль: | $16.24M (36.59 %) |
EPS: | $-0.980 |
FY | 2022 |
Выручка: | $122.65M |
Валовая прибыль: | $70.65M (57.61 %) |
EPS: | $1.170 |
FY | 2021 |
Выручка: | $79.04M |
Валовая прибыль: | $41.99M (53.12 %) |
EPS: | $0.540 |
Financial Reports:
No articles found.
Prophase Labs Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $1.000 | 2018-06-06 |
Last Dividend | $0.300 | 2022-05-24 |
Next Dividend | $0 | N/A |
Payout Date | 2022-06-03 | |
Next Payout Date | N/A | |
# dividends | 6 | -- |
Total Paid Out | $2.40 | -- |
Avg. Dividend % Per Year | 2.00% | -- |
Score | 1.36 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2018 | $1.000 | 44.60% |
2019 | $0.500 | 15.40% |
2020 | $0 | 0.00% |
2021 | $0.300 | 2.84% |
2022 | $0.600 | 8.10% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.378 | 1.500 | -7.56 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.183 | 1.200 | -6.09 | -7.30 | [0 - 0.3] |
returnOnEquityTTM | -0.298 | 1.500 | -4.43 | -6.64 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.28 | 0.800 | 3.59 | 2.87 | [1 - 3] |
quickRatioTTM | 1.994 | 0.800 | 2.98 | 2.38 | [0.8 - 2.5] |
cashRatioTTM | 0.103 | 1.500 | -0.539 | -0.808 | [0.2 - 2] |
debtRatioTTM | 0.142 | -1.500 | 7.63 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -16.95 | 1.000 | -7.39 | -7.39 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.629 | 2.00 | -0.210 | -0.419 | [0 - 30] |
freeCashFlowPerShareTTM | -0.804 | 2.00 | -0.402 | -0.804 | [0 - 20] |
debtEquityRatioTTM | 0.264 | -1.500 | 8.94 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.366 | 1.000 | 7.24 | 7.24 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.487 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.870 | 1.000 | -5.94 | -5.94 | [0.2 - 2] |
assetTurnoverTTM | 0.483 | 0.800 | -0.115 | -0.0916 | [0.5 - 2] |
Total Score | -1.795 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -5.06 | 1.000 | -0.613 | 0 | [1 - 100] |
returnOnEquityTTM | -0.298 | 2.50 | -2.85 | -6.64 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.804 | 2.00 | -0.268 | -0.804 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.629 | 2.00 | -0.210 | -0.419 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.0952 | 1.500 | -3.97 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.256 | 1.000 | -8.89 | 0 | [0.1 - 0.5] |
Total Score | -2.35 |
Prophase Labs Inc
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab methods; and other respiratory pathogen panel molecular testing services, as well as personal genomics products and services. It serves national chain drug, internet-based, and various regional retailers. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа